Germany to start first clinical tests on coronavirus vaccine

Germany has authorized its first clinical test of a vaccine for the novel coronavirus, the country’s regulatory body says, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.

“The Paul-Ehrlich-Institut… has authorized the first clinical trial of a vaccine against COVID-19 in Germany,” the regulatory body says in a statement.

It adds that approval was the “result of a careful assessment of the potential risk/benefit profile of the vaccine candidate.”

AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.